HER2 Support Group Forums - Dr. Slamon describes results of genomic seqncng to determine who benefits from adding

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- her2group (https://her2support.org/vbulletin/forumdisplay.php?f=28)

Lani	06-06-2015 09:01 PM

Dr. Slamon describes results of genomic seqncng to determine who benefits from adding

everolimus (an mTor inhibitor which ffeecets the PI3k pathway) to herceptin in Stage IV patients

http://meetinglibrary.asco.org/content/112020?media=vm

sarah

06-07-2015 03:44 AM

Re: Dr. Slamon describes results of genomic seqncng to determine who benefits from ad

yes interesting and here's more on the subject:
http://www.ascopost.com/ViewNews.aspx?nid=20674
sarah

All times are GMT -7. The time now is 10:56 PM.